Is the Fed Put Back in Play, and What’s Next for Biogen? 9/28/22
Stocks rallying after hitting the year’s lows as one central bank indicated it’s willing to step in to calm the markets. But will the Fed follow suit or is there more turmoil ahead? Plus Biogen making a major breakthrough with its Alzheimer’s treatment. What it means for the stock and the rest of the biotech space.
2022-09-28
43 min
Available Results
Generated results are saved to the knowledge database for reuse and search.
No generated results are available for this episode yet.
Extract Knowledge
Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.
Generated results for public episodes are saved to the knowledge database so they can be reused and searched later.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
No chapters available.